Cargando…
Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
Glioblastoma (GBM) is the most aggressive type of brain tumor. Despite the multimodal therapies, the effectiveness of traditional treatments is not much satisfying. In recent years, immunotherapy has become the focus of tumor treatment. Unlike traditional treatments that directly target tumor cells,...
Autores principales: | Tang, Lin, Zhang, Ming, Liu, Chaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149074/ https://www.ncbi.nlm.nih.gov/pubmed/35651605 http://dx.doi.org/10.3389/fimmu.2022.882257 |
Ejemplares similares
-
Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022) -
Revolutionizing cancer treatment: nanotechnology-enabled photodynamic therapy and immunotherapy with advanced photosensitizers
por: Jia, Jiedong, et al.
Publicado: (2023) -
Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases
por: Yang, Lu, et al.
Publicado: (2022) -
Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021) -
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020)